Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial
Authors (first, second and last of 13)
Volume 17, issue 1, December 2024
23 articles in this issue
-
-
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
Authors (first, second and last of 5)
-
Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
Authors (first, second and last of 28)
-
Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma
Authors (first, second and last of 7)
-
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel
Authors (first, second and last of 20)
-
-
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
Authors (first, second and last of 26)
-
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Authors (first, second and last of 16)
-
-
Targeted protein degradation in hematologic malignancies: latest updates from the 2023 ASH annual meeting
Authors (first, second and last of 7)
This is part of 2 collections: -
-
Decoding the glycoproteome: a new frontier for biomarker discovery in cancer
Authors (first, second and last of 8)
-
Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkers
Authors (first, second and last of 18)
-
Optical nanomaterial-based detection of biomarkers in liquid biopsy
Authors (first, second and last of 4)
-
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion
Authors (first, second and last of 14)
-
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Authors (first, second and last of 27)
-
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation
Authors (first, second and last of 35)
-
Metabolic reprogramming in the tumor microenvironment of liver cancer
Authors (first, second and last of 4)
-
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Authors (first, second and last of 7)
-
Vaccines: a promising therapy for myelodysplastic syndrome
Authors (first, second and last of 10)
This is part of 2 collections:
-
-
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
Authors (first, second and last of 39)
-
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
Authors (first, second and last of 17)
